News

The Prognostic Nutritional Index (PNI) and systemic oxidative stress (SOS) score are independently associated with poorer ...
Allogeneic hematopoietic cell transplantation (allo-HCT) is feasible in older patients with myelodysplastic syndrome (MDS), ...
An expert discusses how real-world evidence and patient-reported outcomes support luspatercept’s clinical benefits, while ...
Myelodysplastic syndromes are diseases of older patients. The median age in the United States is 76 years old, meaning that most of your patients are going to be in their eighth decade of life, ...
An expert discusses how optimal sequencing of therapies remains unclear in lower-risk MDS, with emerging combination ...
Reblozyl sales surged 35% in Q1 for BMY, but a failed phase III study clouds expansion plans amid stiff anemia drug ...
Bruce Feinberg, DO: Hello, and welcome to this AJMC® Peer Exchange program titled “Oral Therapy Considerations for the Management of Myelodysplastic Syndromes.” I’m Dr Bruce Feinberg, vice ...
Myelodysplastic syndromes are a heterogeneous group of neoplastic hematopoietic stem cell disorders. The common features of the disease include (1) clinical presentation with variant cytopenias and ...
SAN DIEGO — Genetic mutations related to myelodysplastic syndrome occurred significantly more often among people who smoked than nonsmokers, according to study results presented at ASH Annual ...
In this study, we set out to evaluate the frequency of mutations in 20 myelodysplastic syndrome-associated genes in 53 individuals with pancytopenia in which bone marrow evaluation failed to meet ...
Bone marrow features of myelodysplastic syndromes with moderate-to-severe bone marrow fibrosis. (a) Hematoxylin and eosin (H&E magnification × 500) showing a hypercellular bone marrow with ...